Pacific Hospital Supply Co Ltd

Pacific Hospital Supply Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.14, significantly below the industry median of 0.45, indicating a low reliance on debt financing. The company's liquidity position is mixed: while it holds TWD 162.86 million in cash and equivalents, its net cash position is negative after subtracting total debt of TWD 428.51 million. The current ratio of 3.49 suggests strong short-term liquidity, with current assets comfortably covering current liabilities.

Profitability metrics show the company is performing above industry norms. Return on equity (ROE) of 12.9% exceeds the industry median of 9.2%, and return on assets (ROA) of 9.77% is well above the median of 6.8%. These figures suggest efficient use of equity and asset base to generate returns. Gross margin of 30.7% (TWD 738.89 million gross profit on TWD 2.41 billion revenue) is in line with the industry median of 31.2%, but operating margin of 19.7% (TWD 473.35 million operating income) is slightly below the median of 21.5%, indicating potential pressure on operating expenses.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of segmentation exposes the company to operational and market-specific risks, as there is no clear breakdown of revenue by product line or geographic region. The absence of geographic diversification is a concern in an industry where regional healthcare policies and demand can vary significantly.

Growth trajectory appears modest. Revenue of TWD 2.41 billion in the latest period shows no year-over-year growth data provided, but the company's free cash flow of TWD 77.53 million and operating cash flow of TWD 542.09 million suggest it has the capacity to fund operations and potentially reinvest in the business. Analysts have assigned a "Hold" rating, with no strong buy or sell recommendations, indicating a neutral outlook.

Risk factors include liquidity concerns due to the negative net cash position and the potential for dilution, though the risk is currently assessed as low. The company has not issued additional shares in the latest period, and there is no indication of dilutive financing in the near term. However, the risk assessment flags a negative net cash position as a key liquidity flag, which could become more pressing if capital expenditures increase or operating cash flow declines.

Recent events include the publication of the latest financial results, which show a net income of TWD 382.87 million and a total equity of TWD 2.97 billion. No material events such as mergers, acquisitions, or regulatory changes have been disclosed in the latest filings or transcripts, suggesting a stable but uneventful period for the company.